Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(33%)

Phase Distribution

Ph phase_1
2
67%
Ph phase_3
1
33%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
Phase 3Large-scale testing
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Terminated(2)

Detailed Status

Withdrawn1
Enrolling by invitation1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (66.7%)
Phase 31 (33.3%)

Trials by Status

withdrawn133%
enrolling_by_invitation133%
terminated133%

Recent Activity

0 active trials
Showing 3 of 3
enrolling_by_invitationphase_3

Rezafungin Prophylaxis in Liver Transplant

NCT06774144
withdrawnphase_1

Rezafungin Pharmacokinetics in Patients on ECMO

NCT06329518
terminatedphase_1

Safety and Pharmacokinetics of Rezafungin

NCT04117607

Clinical Trials (3)

Showing 3 of 3 trials
NCT06774144Phase 3

Rezafungin Prophylaxis in Liver Transplant

Enrolling By Invitation
NCT06329518Phase 1

Rezafungin Pharmacokinetics in Patients on ECMO

Withdrawn
NCT04117607Phase 1

Safety and Pharmacokinetics of Rezafungin

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3